Literature DB >> 11055509

Role of mesenchymal stem cells in hematopoietic stem cell transplantation.

S M Devine1, R Hoffman.   

Abstract

Within the bone marrow stroma are multipotential cells which are capable of differentiation into a number of mesenchymal cell lineages. These cells, termed mesenchymal stem cells, have recently been identified and characterized in humans. Many studies indicate that the bone marrow stroma is damaged following bone marrow transplantation. Since the marrow stroma is critical for the maintenance of hematopoiesis, its ability to support hematopoiesis following stem cell transplantation may be impaired. Animal models suggest that the transplantation of healthy stromal elements, including mesenchymal stem cells, may enhance the ability of the bone marrow microenvironment to support hematopoiesis after stem cell transplantation. Here the authors review recent data that suggest that mesenchymal stem cells may possess therapeutic value not only for the repair of damaged mesenchymal tissues following hematopoietic stem cell transplantation, but also as potential vectors for the delivery of corrective genes.

Entities:  

Mesh:

Year:  2000        PMID: 11055509     DOI: 10.1097/00062752-200011000-00007

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.284


  33 in total

1.  Recent Patents Pertaining to Immune Modulation and Musculoskeletal Regeneration with Wharton's Jelly Cells.

Authors:  Limin Wang; Mark L Weiss; Michael S Detamore
Journal:  Recent Pat Regen Med       Date:  2013

Review 2.  Bone-marrow-derived stem cells--our key to longevity?

Authors:  Mariusz Z Ratajczak; Ewa K Zuba-Surma; Boguslaw Machalinski; Magdalena Kucia
Journal:  J Appl Genet       Date:  2007       Impact factor: 3.240

Review 3.  Hunt for pluripotent stem cell -- regenerative medicine search for almighty cell.

Authors:  Mariusz Z Ratajczak; Ewa K Zuba-Surma; Marcin Wysoczynski; Wu Wan; Janina Ratajczak; Wojciech Wojakowski; Magda Kucia
Journal:  J Autoimmun       Date:  2008-02-04       Impact factor: 7.094

4.  Treatment effect of low intensity pulsed ultrasound on leukopenia induced by cyclophosphamide in rabbits.

Authors:  Baoru Liu; Yueping Luo; Dong Luo; Weichen Zhou; Yu Zhang; Ruixin He; Junshu Li; Yong Wang; Yan Wang; Wenzhi Chen
Journal:  Am J Transl Res       Date:  2017-07-15       Impact factor: 4.060

Review 5.  Mesenchymal stem cells: immune evasive, not immune privileged.

Authors:  James A Ankrum; Joon Faii Ong; Jeffrey M Karp
Journal:  Nat Biotechnol       Date:  2014-02-23       Impact factor: 54.908

6.  Orthogonal potency analysis of mesenchymal stromal cell function during ex vivo expansion.

Authors:  Danika Khong; Matthew Li; Amy Singleton; Ling-Yee Chin; Shilpaa Mukundan; Biju Parekkadan
Journal:  Exp Cell Res       Date:  2017-11-11       Impact factor: 3.905

7.  Cotransplanted bone marrow derived mesenchymal stem cells (MSC) enhanced engraftment of hematopoietic stem cells in a MSC-dose dependent manner in NOD/SCID mice.

Authors:  Dong Hyun Kim; Keon Hee Yoo; Young Sook Yim; Jaewon Choi; Soo Hyun Lee; Hye Lim Jung; Ki Woong Sung; Sung-Eun Yang; Won Il Oh; Yoon-Sun Yang; Sang-Hee Kim; Sang-Yun Choi; Hong Hoe Koo
Journal:  J Korean Med Sci       Date:  2006-12       Impact factor: 2.153

8.  Doxorubicin induces the DNA damage response in cultured human mesenchymal stem cells.

Authors:  Séverine Cruet-Hennequart; Áine M Prendergast; Georgina Shaw; Frank P Barry; Michael P Carty
Journal:  Int J Hematol       Date:  2012-10-18       Impact factor: 2.490

9.  Study of oncogenic transformation in ex vivo expanded mesenchymal cells, from paediatric bone marrow.

Authors:  D M Choumerianou; H Dimitriou; C Perdikogianni; G Martimianaki; M Riminucci; M Kalmanti
Journal:  Cell Prolif       Date:  2008-12       Impact factor: 6.831

10.  MePR: a novel human mesenchymal progenitor model with characteristics of pluripotency.

Authors:  Marco Miceli; Gianluigi Franci; Carmela Dell'Aversana; Francesca Ricciardiello; Francesca Petraglia; Annamaria Carissimo; Lucia Perone; Giuseppe Maria Maruotti; Marco Savarese; Pasquale Martinelli; Massimo Cancemi; Lucia Altucci
Journal:  Stem Cells Dev       Date:  2013-05-24       Impact factor: 3.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.